Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Tobramycin in Cystic Fibrosis
NCT00004829Phase 3Completed
- Sponsor
- Food and Drug Administration
- Start
- Jun 1995
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tobramycin in cystic fibrosis (CF), sponsored by Food and Drug Administration. Started Jun 1995; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00004829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004829.